Can anyone or Prof please explain what it means by orphan drug status? Why is it good for PRR? etc.
Sorry, I am pretty new in this area.
Wiki as reference is ok. I know I can do a google search, but I think it is better that someone who knows these thing explain it in a short and nice, straight to the point kind of way; Also good for people who read this thread to gain more understanding.
Thanks!
patient numbers required for clinical study , page-25
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $406.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $1.341M | 4.777M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 167966 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 138542 | 5 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |